(Q48498835)

English

Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study

scientific article published in June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

author name string

P Stanzione

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

M G Marciani

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

F Izzi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

A Cervellino

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

P Giacomini

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

L Brusa

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

K Grossi

9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

M Pierantozzi

10

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

113

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

12

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

1909-1913

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

Parkinson's disease and sleepiness: an integral part of PD.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's Disease Sleep Scale

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Daytime sleepiness and other sleep disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

L-dopa-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Cabergoline in Parkinson's disease: long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0490-X

21 January 2018

Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep attacks and Parkinson's disease treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Waking up to sleep episodes in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep in healthy elderly subjects: a 24-hour ambulatory polysomnographic study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parkinson's disease and sleep

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sleep latency tests during the constant routine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A community-based study of sleep disorders in patients with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep disorders and sleep effect in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep attacks in patients taking dopamine agonists: review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic and Pharmacokinetic Features of Cabergoline

1 reference

https://pubmed.ncbi.nlm.nih.gov/16736238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00702-006-0490-X

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16736238

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48498835&oldid=2209530555"